{"id":"https://openalex.org/W4404398707","doi":"https://doi.org/10.1186/s12933-024-02500-y","title":"Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives","display_name":"Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives","alternate_titles":[],"publication_year":2024,"publication_date":"2024-11-15","ids":{"openalex":"https://openalex.org/W4404398707","doi":"https://doi.org/10.1186/s12933-024-02500-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/39548500","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11568621"},"language":"en","primary_location":{"id":"doi:10.1186/s12933-024-02500-y","doi":"https://doi.org/10.1186/s12933-024-02500-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-024-02500-y","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-024-02500-y","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4404398707"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-024-02500-y","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088417487","display_name":"Kosuke Sawami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177136067","display_name":"Saga University","ror":"https://ror.org/04f4wg107","country_code":"JP","type":"education","lineage":["https://openalex.org/I177136067"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kosuke Sawami","raw_affiliation_strings":["Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan","Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]},{"raw_affiliation_string":"Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan","institution_ids":["https://openalex.org/I177136067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019753658","display_name":"Atsushi Tanaka","orcid":"https://orcid.org/0000-0003-3352-7661","observed_orcids":["https://orcid.org/0000-0003-3352-7661"]},"institutions":[{"id":"https://openalex.org/I177136067","display_name":"Saga University","ror":"https://ror.org/04f4wg107","country_code":"JP","type":"education","lineage":["https://openalex.org/I177136067"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Atsushi Tanaka","raw_affiliation_strings":["Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. tanakaa2@cc.saga-u.ac.jp","Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. tanakaa2@cc.saga-u.ac.jp","institution_ids":["https://openalex.org/I177136067"]},{"raw_affiliation_string":"Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan","institution_ids":["https://openalex.org/I177136067"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052966356","display_name":"Koichi Node","orcid":"https://orcid.org/0000-0002-2534-0939","observed_orcids":["https://orcid.org/0000-0002-2534-0939"]},"institutions":[{"id":"https://openalex.org/I177136067","display_name":"Saga University","ror":"https://ror.org/04f4wg107","country_code":"JP","type":"education","lineage":["https://openalex.org/I177136067"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Koichi Node","raw_affiliation_strings":["Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan","institution_ids":["https://openalex.org/I177136067"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5019753658"],"corresponding_institution_ids":["https://openalex.org/I177136067"],"apc_list":{"value":3990,"currency":"USD","value_usd":3990},"apc_paid":{"value":3990,"currency":"USD","value_usd":3990},"fwci":2.6492,"has_fulltext":true,"cited_by_count":66,"citation_normalized_percentile":{"value":0.92878942,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"23","issue":"1","first_page":"410","last_page":"410"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9890000224113464},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/finerenone","display_name":"finerenone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.7689999938011169},{"id":"https://openalex.org/keywords/renal-outcomes","display_name":"renal outcomes","score":0.9340000152587891},{"id":"https://openalex.org/keywords/heart-failure-with-preserved-ejection-fraction","display_name":"heart failure with preserved ejection fraction","score":0.9240000247955322},{"id":"https://openalex.org/keywords/heart-failure-with-reduced-ejection-fraction","display_name":"heart failure with reduced ejection fraction","score":0.9539999961853027},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cardiorenal-protection","display_name":"cardiorenal protection","score":0.871999979019165},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.7670000195503235},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9184514284133911},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.7426955103874207},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.695172131061554},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.678264319896698},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5629101395606995},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.541366457939148},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5217243432998657},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5155186653137207},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4915715157985687},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.42924806475639343},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39420849084854126},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2689626216888428},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.16322296857833862},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08600419759750366},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002319","descriptor_name":"Cardiovascular System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002319","descriptor_name":"Cardiovascular System","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12933-024-02500-y","doi":"https://doi.org/10.1186/s12933-024-02500-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-024-02500-y","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-024-02500-y","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11568621","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11568621","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11568621/pdf/12933_2024_Article_2500.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Diabetol","raw_type":"Text"},{"id":"pmid:39548500","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39548500","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular diabetology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:35107f0646fc46afa0af76b5cc1e3b4a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/35107f0646fc46afa0af76b5cc1e3b4a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-11 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12933-024-02500-y","doi":"https://doi.org/10.1186/s12933-024-02500-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-024-02500-y","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-024-02500-y","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404398707.pdf","grobid_xml":"https://content.openalex.org/works/W4404398707.grobid-xml"},"referenced_works_count":60,"referenced_works":["https://openalex.org/W2063400466","https://openalex.org/W2065623326","https://openalex.org/W2139634859","https://openalex.org/W2141082354","https://openalex.org/W2170271198","https://openalex.org/W2282578582","https://openalex.org/W2335779504","https://openalex.org/W2425644022","https://openalex.org/W2463902228","https://openalex.org/W2475233216","https://openalex.org/W2505843168","https://openalex.org/W2519510391","https://openalex.org/W2542456927","https://openalex.org/W2612056900","https://openalex.org/W2741776549","https://openalex.org/W2750733474","https://openalex.org/W2754041380","https://openalex.org/W2767087620","https://openalex.org/W2894746763","https://openalex.org/W2916296804","https://openalex.org/W2948612418","https://openalex.org/W3026907472","https://openalex.org/W3081300539","https://openalex.org/W3094429645","https://openalex.org/W3102119644","https://openalex.org/W3177365549","https://openalex.org/W3194763937","https://openalex.org/W3195404919","https://openalex.org/W3200446817","https://openalex.org/W3207290141","https://openalex.org/W3214731876","https://openalex.org/W4206077470","https://openalex.org/W4206445899","https://openalex.org/W4225287557","https://openalex.org/W4282925091","https://openalex.org/W4293353625","https://openalex.org/W4294771877","https://openalex.org/W4296802076","https://openalex.org/W4300688387","https://openalex.org/W4301390966","https://openalex.org/W4308559981","https://openalex.org/W4361219083","https://openalex.org/W4362522003","https://openalex.org/W4376647457","https://openalex.org/W4376872353","https://openalex.org/W4385409351","https://openalex.org/W4386154055","https://openalex.org/W4388592674","https://openalex.org/W4388609820","https://openalex.org/W4389560599","https://openalex.org/W4393255879","https://openalex.org/W4393871692","https://openalex.org/W4396873474","https://openalex.org/W4398781461","https://openalex.org/W4399940216","https://openalex.org/W4400978809","https://openalex.org/W4402066678","https://openalex.org/W4402066700","https://openalex.org/W4402101139","https://openalex.org/W4402101440"],"related_works":["https://openalex.org/W4414663736","https://openalex.org/W4408197853","https://openalex.org/W4404710290","https://openalex.org/W4402942708","https://openalex.org/W7168122732","https://openalex.org/W7130386320","https://openalex.org/W4283013961","https://openalex.org/W4404599625","https://openalex.org/W4280523813","https://openalex.org/W3212713672"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1,170],"receptor":[2,171],"agonists":[3],"(GLP-1RAs)":[4],"have":[5],"a":[6],"reliable":[7],"hypoglycaemic":[8],"and":[9,41,69,77,89,105,137,143,160,163],"weight-loss":[10],"effect":[11],"that":[12,87],"can":[13],"intervene":[14],"in":[15,32,45,74,101],"obesity,":[16],"which":[17],"is":[18,58],"the":[19,34,113,134,150],"basis":[20],"of":[21,36,82,115,140,157],"type":[22],"2":[23,92,193],"diabetes":[24,48],"pathology.":[25],"GLP-1RA":[26,88],"therapy":[27,95,120,142],"has":[28],"shown":[29],"potential":[30,135],"benefits":[31,61,139],"reducing":[33],"risk":[35,51],"major":[37],"adverse":[38],"cardiovascular":[39,53,136],"events":[40,108],"improving":[42],"kidney":[43,164],"outcomes":[44,73],"patients":[46,75],"with":[47,65,76,176,183],"at":[49],"high":[50],"for":[52,149],"disease.":[54],"More":[55],"recent":[56],"evidence":[57],"expanding":[59],"their":[60],"to":[62,117,132,144],"heart":[63,102,174,181],"failure":[64,103,175,182],"preserved":[66,177],"ejection":[67,178,185],"fraction":[68],"clinically":[70],"important":[71],"renal":[72,106,138],"without":[78],"diabetes.":[79],"Some":[80],"sub-analyses":[81],"large":[83],"clinical":[84,155],"trials":[85],"suggest":[86],"sodium-glucose":[90,191],"cotransporter":[91,192],"inhibitor":[93],"combination":[94,119,141],"may":[96],"provide":[97,123],"more":[98],"significant":[99],"reductions":[100],"hospitalization":[104],"composite":[107],"than":[109],"each":[110],"alone.":[111],"Moreover,":[112],"addition":[114],"finerenone":[116,161],"this":[118],"could":[121],"potentially":[122],"stronger":[124],"cardiorenal":[125],"protective":[126],"benefits.":[127],"Further":[128],"studies":[129],"are":[130],"needed":[131],"assess":[133],"determine":[145],"suitable":[146],"patient":[147],"population":[148],"therapy.":[151],"Graphical":[152],"abstract":[153],"Suspected":[154],"impacts":[156],"GLP-1RAs,":[158],"SGLT2is,":[159],"oncardiovascular":[162],"outcomes.":[165],"CV,":[166],"cardiovascular;":[167],"GLP-1RA,":[168],"glucagon-like":[169],"agonist;":[172],"HFpEF,":[173],"fraction;":[179,186],"HFrEF,":[180],"reduced":[184],"MI,":[187],"myocardial":[188],"infarction;":[189],"SGLT2i,":[190],"inhibitor.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4404398707","counts_by_year":[{"year":2026,"cited_by_count":35},{"year":2025,"cited_by_count":31}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2024-11-15T00:00:00"}
